IMTX
Price
$6.97
Change
-$0.07 (-0.99%)
Updated
Jan 8, 11:38 AM (EDT)
70 days until earnings call
KYMR
Price
$41.07
Change
+$0.15 (+0.37%)
Updated
Jan 8, 12:01 PM (EDT)
43 days until earnings call
Ad is loading...

IMTX vs KYMR

Header iconIMTX vs KYMR Comparison
Open Charts IMTX vs KYMRBanner chart's image
Immatics
Price$6.97
Change-$0.07 (-0.99%)
Volume$100
CapitalizationN/A
Kymera Therapeutics
Price$41.07
Change+$0.15 (+0.37%)
Volume$100
CapitalizationN/A
IMTX vs KYMR Comparison Chart
Loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMTX vs. KYMR commentary
Jan 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a StrongBuy and KYMR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 08, 2025
Stock price -- (IMTX: $7.04 vs. KYMR: $40.92)
Brand notoriety: IMTX and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 75% vs. KYMR: 98%
Market capitalization -- IMTX: $884.88M vs. KYMR: $2.58B
IMTX [@Biotechnology] is valued at $884.88M. KYMR’s [@Biotechnology] market capitalization is $2.58B. The market cap for tickers in the [@Biotechnology] industry ranges from $382.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMTX and KYMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 6 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • IMTX’s TA Score: 6 bullish, 2 bearish.
  • KYMR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than KYMR.

Price Growth

IMTX (@Biotechnology) experienced а -0.98% price change this week, while KYMR (@Biotechnology) price change was +1.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.07%. For the same industry, the average monthly price growth was +1.39%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

IMTX is expected to report earnings on May 20, 2025.

KYMR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+6.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.58B) has a higher market cap than IMTX($885M). KYMR YTD gains are higher at: 1.715 vs. IMTX (-0.985). IMTX has higher annual earnings (EBITDA): -36.26M vs. KYMR (-160.96M). KYMR has more cash in the bank: 550M vs. IMTX (491M). IMTX has less debt than KYMR: IMTX (16M) vs KYMR (88.2M). IMTX has higher revenues than KYMR: IMTX (116M) vs KYMR (87.6M).
IMTXKYMRIMTX / KYMR
Capitalization885M2.58B34%
EBITDA-36.26M-160.96M23%
Gain YTD-0.9851.715-57%
P/E RatioN/AN/A-
Revenue116M87.6M132%
Total Cash491M550M89%
Total Debt16M88.2M18%
FUNDAMENTALS RATINGS
IMTX: Fundamental Ratings
IMTX
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMTXKYMR
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 22 days ago
77%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGOIX24.59-0.02
-0.08%
First Eagle Overseas I
NWGSX30.60-0.09
-0.29%
Nationwide WCM Focused Sm Cp Instl Svc
RGCEX15.25-0.13
-0.85%
Columbia Select Global Equity C
WCMNX12.89-0.12
-0.92%
WCM Small Cap Growth Investor
BFGUX49.32-0.51
-1.02%
Baron Focused Growth R6

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with ADMA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then ADMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-3.30%
ADMA - IMTX
35%
Loosely correlated
-4.39%
RXRX - IMTX
34%
Loosely correlated
-5.79%
KRRO - IMTX
33%
Poorly correlated
-7.23%
MRUS - IMTX
33%
Poorly correlated
+2.12%
FULC - IMTX
31%
Poorly correlated
-0.61%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+2.56%
CCCC - KYMR
61%
Loosely correlated
-5.62%
ERAS - KYMR
48%
Loosely correlated
+3.00%
RXRX - KYMR
47%
Loosely correlated
-5.79%
XENE - KYMR
47%
Loosely correlated
+0.05%
TRDA - KYMR
46%
Loosely correlated
-4.43%
More